Peginterferon plus ribavirin versus interferon plus ribavirin for chronic hepatitis C

Medicine & Life Sciences

• Ribavirin 100%
• Chronic Hepatitis C 92%
• Interferons 81%
• Odds Ratio 37%
• Confidence Intervals 31%
• Liver 11%
• Mortality 11%
• Morbidity 10%
• Intention to Treat Analysis 10%
• Quality of Life 8%
• Fatigue 7%
• peginterferon alfa-2b 7%
• peginterferon alfa-2a 6%
• Injection Site Reaction 6%
• Bias 6%
• Amantadine 5%
• Randomized Controlled Trials 5%
• Therapeutics 5%
• Asthenia 5%
• Gray Literature 5%
• Myalgia 4%
• Alopecia 4%
• Arthralgia 4%
• Data Accuracy 4%
• Sleep Initiation and Maintenance Disorders 4%
• Appetite 4%
• Pruritus 4%
• Neutropenia 4%
• Exanthema 4%
• Congresses 4%
• Viral Load 4%
• Thrombocytopenia 4%
• Hepacivirus 4%
• Serum 4%
• Nausea 3%
• MEDLINE 3%
• Antiviral Agents 3%
• Headache 3%
• Anemia 3%
• Diarrhea 3%
• Thyroid Gland 3%
• Weight Loss 3%
• Observational Studies 3%
• Fever 3%
• History 3%
• Data Analysis 3%
• Meta-Analysis 3%
• Genotype 3%
• RNA 3%
• Depression 2%